tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Advertisement

ARS Pharmaceuticals (SPRY) Technical Analysis

Compare
523 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
6Neutral
12Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
ARS Pharmaceuticals’s (SPRY) Moving Averages Convergence Divergence (MACD) indicator is -0.52, suggesting ARS Pharmaceuticals is a Buy.
ARS Pharmaceuticals’s (SPRY) 20-Day exponential moving average is 9.51, while ARS Pharmaceuticals’s (SPRY) share price is $8.71, making it a Sell.
ARS Pharmaceuticals’s (SPRY) 50-Day exponential moving average is 10.67, while ARS Pharmaceuticals’s (SPRY) share price is $8.71, making it a Sell.

ARS Pharmaceuticals (SPRY) Pivot Points

Nov 07, 2025, 10:06 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.98
8.16
8.43
8.61
8.88
9.06
9.33
Fibonacci
8.16
8.33
8.43
8.61
8.78
8.88
9.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ARS Pharmaceuticals (SPRY) Moving Averages

Nov 07, 2025, 10:06 AM
Period
Simple
Exponential
MA5
8.79Buy
8.91Buy
MA10
9.06Sell
9.12Sell
MA20
9.80Sell
9.51Sell
MA50
10.16Sell
10.67Sell
MA100
13.43Sell
11.99Sell
MA200
13.27Sell
12.43Sell
ARS Pharmaceuticals’s (SPRY) 10-Day exponential moving average is 9.12, while ARS Pharmaceuticals’s (SPRY) share price is $8.71, making it a Sell.
ARS Pharmaceuticals’s (SPRY) 100-Day exponential moving average is 11.99, while ARS Pharmaceuticals’s (SPRY) share price is $8.71, making it a Sell.
ARS Pharmaceuticals’s (SPRY) stock price is $8.71 and ARS Pharmaceuticals’s (SPRY) 50-day simple moving average is 10.16, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) stock price is $8.71 and ARS Pharmaceuticals’s (SPRY) 100-day simple moving average is 13.43, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) stock price is $8.71 and ARS Pharmaceuticals’s (SPRY) 200-day simple moving average is 13.27, creating a Sell signal.

ARS Pharmaceuticals (SPRY) Technical Indicators

Nov 07, 2025, 10:06 AM
Name
Value
Implied Action
RSI (14)
40.49
Neutral
STOCH (9,6)
31.42
Neutral
STOCHRSI (14)
20.03
Neutral
MACD (12,26)
-0.52
Buy
ADX (14)
27.17
Neutral
Williams %R
-64.41
Buy
CCI (14)
-79.37
Neutral
ATR (14)
0.56
-
Ultimate Oscillator
50.58
Neutral
ROC
-10.48
Sell
ARS Pharmaceuticals’s (SPRY) Relative Strength Index (RSI) is 40.49, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Trend Strength Indicator (ADX) is 27.17, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Commodity Channel Index (CCI) is -79.37, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Price Rate of Change (ROC) is -10.48, creating a Sell signal.

FAQ

Is SPRY a Buy, Hold, or Sell?
Based on SPRY’s technical indicators, SPRY is a Sell.
    What is SPRY’s RSI (14)?
    SPRY’s RSI (14) is 40.49, which suggests SPRY is a Neutral.
      What is SPRY’s MACD?
      SPRY’s MACD is -0.52, which suggests SPRY is a Buy.
        What is SPRY’s 5-day moving average?
        SPRY’s 5-day moving average is 8.79, which suggests SPRY is a Buy.
          What is SPRY’s 20-day moving average?
          SPRY 20-day moving average is 9.80, which suggests SPRY is a Sell.
            What is SPRY’s 50-day moving average?
            SPRY’s 50-day moving average is 10.16, which suggests SPRY is a Sell.
              What is SPRY’s 200-day moving average?
              SPRY’s 200-day moving average is 13.27, which suggests SPRY is a Sell.
                What is SPRY’s Williams % R (14)?
                SPRY’s Williams % R (14) is -64.41, which suggests SPRY is a Buy.
                  What is SPRY’s CCI (14)?
                  SPRY’s CCI (14) is -79.37, which suggests SPRY is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis